People with such serious medical conditions as glaucoma and multiple sclerosis may smoke marijuana to deliver a range of chemicals that they believe helps improve their conditions. The problem is that a joint might just be one of the least effective methods to deliver some of the 90+ cannabinoids found in cannabis.
ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) was one of the first companies to obtain a cannabis production license in Canada, and it continues going strong among the country’s limited number of licensed growers—only 62 to date.
BC Bud. BC Tweed. Canopy Growth establishes joint venture to convert 1.3 million square feet of existing greenhouse in British Columbia. The joint venture includes an option for additional 1.7 Million sq. ft. greenhouse.
Organigram Holdings Inc. (TSX VENTURE:OGI) (OTCQB:OGRMF) is undergoing a production-facility expansion that will more than triple the size of its operations. The multi-million-dollar project will meet the growing needs of the Company’s medical patient base, as well as prepare Organigram for the legal, adult-recreational marijuana market.
India Globalization Capital (NYSE MKT: IGC) recently announced that it is assembling a line of cannabis-based medical dispensary products targeting Alzheimer’s disease.
Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced the launch of the first cryptocurrency daily video newscast in the Chinese language broadcast from the NYSE.
Marijuana Company of America (OTC: MCOA) and Global Hemp Group (OTC: GBHPF) (CSE: GHG) this morning announced their entry into a letter of intent with licensed cannabinoid producer Space Cowboys, Inc. for the purposes of forming a joint venture.
Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced the addition of Dr. Mauro Maccarrone to its scientific advisory board.
PotNetwork Holding, Inc. (OTC: POTN) this morning announced its appointment of Dr. Michael McKenzie, an industry-leading physician, to its advisory board.
Payment solutions company Global Payout, Inc. (OTC: GOHE) today announced that MoneyTrac Technology, Inc., its majority-owned subsidiary, is currently in the final stages of facilitating an exclusive joint venture partnership agreement aimed at bringing effective banking solutions to businesses operating in the rapidly expanding cannabis industry.
InMed Pharmaceuticals, Inc. (CSE: IN; OTCQB: IMLFF), announces the addition of Dr. Mauro Maccarrone to its Scientific Advisory Board. Dr. Maccarrone has vast experience in the field of cannabinoid research.
SeeThruEquity has updated its coverage and maintained its price target of $3.75 on shares of ChineseInvestors.com, Inc.’s (OTCQB: CIIX) stock.
Algae Dynamics Corp. (OTC: ADYNF), a company engaged in developing unique health products and pharmaceuticals utilizing cannabis and algae oils, is well-positioned to benefit from the impending legalization of recreational marijuana in Canada, which the Canadian government is endeavoring to accomplish by mid-2018.
The House of Commons Health Committee has completed its study of Bill C-45, the government’s bill to legalize marijuana, and has made some tweaks to the government’s proposal, including cutting out the height restriction on homegrown marijuana plants.
Canada is set to become the first advanced industrialized nation to legalize and regulate marijuana from production to consumption by next July, but increasingly, Canadians are wondering: What’s the hurry?
